{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:13:44Z","timestamp":1792761224400,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Heart Failure"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    The clinical features associated with liver disease in patients with advanced heart failure are poorly defined. We investigated the histopathologic spectrum of liver disease in a contemporary population with heart failure to identify the clinical correlates of hepatic fibrosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods and Results\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    We identified 61 patients with advanced heart failure undergoing evaluation for ventricular assist device or cardiac transplantation from 1995 to 2006, who had liver tissue obtained during the same time period. Electronic medical records were reviewed for clinical data. Biopsy specimens were scored for hepatic fibrosis. Forty-seven patients (79.7%) had hepatic fibrosis on liver biopsy. Of these, 47% had severe fibrosis (grade 3 or 4). Relative to those without fibrosis, patients with hepatic fibrosis were more likely to have renal dysfunction, moderate or severe tricuspid regurgitation (odds ratio, 5.0; 95% CI, 1.2 to 21.7), and obstructive or mixed liver function test abnormalities (odds ratio, 5.7; 95% CI, 1.4 to 22.3). As anticipated, patients with no or mild fibrosis (grade 1 or 2) on transjugular liver biopsy were more likely to undergo ventricular assist device or heart transplant than patients with severe fibrosis (odds ratio, 7.8; 95% CI, 1.4 to 44.0). Accordingly, patients with severe fibrosis were less likely to be alive at the time of data collection (odds ratio, 0.07; 95% CI, 0.01 to 0.42).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusions\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Hepatic fibrosis is common in patients with advanced heart failure. Renal dysfunction, significant tricuspid regurgitation and abnormal liver function tests are associated with hepatic fibrosis, but the predictive value of other clinical features is limited. Liver biopsy should be considered in patients undergoing ventricular assist device or transplant evaluation.\n                  <\/jats:p>","DOI":"10.1161\/circheartfailure.109.872556","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T22:24:01Z","timestamp":1255559041000},"page":"59-64","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":80,"title":["Clinical Predictors of Hepatic Fibrosis in Chronic Advanced Heart Failure"],"prefix":"10.1161","volume":"3","author":[{"given":"Jill M.","family":"Gelow","sequence":"first","affiliation":[{"name":"From the Cardiovascular Division (J.M.G., A.S.D., C.P.H., J.N.G., M.M.G., J.C.F.), Brigham and Women\u2019s Hospital, Boston, Mass; Cardiovascular Division (J.M.G.), Oregon Health and Science University, Portland, Ore; Cardiovascular Division (C.P.H.), Beth Israel Deaconess Medical Center, Boston, Mass; and Cardiovascular Division (J.C.F.), University Hospital-Case Medical Center, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division (J.M.G., A.S.D., C.P.H., J.N.G., M.M.G., J.C.F.), Brigham and Women\u2019s Hospital, Boston, Mass; Cardiovascular Division (J.M.G.), Oregon Health and Science University, Portland, Ore; Cardiovascular Division (C.P.H.), Beth Israel Deaconess Medical Center, Boston, Mass; and Cardiovascular Division (J.C.F.), University Hospital-Case Medical Center, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Hochberg","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division (J.M.G., A.S.D., C.P.H., J.N.G., M.M.G., J.C.F.), Brigham and Women\u2019s Hospital, Boston, Mass; Cardiovascular Division (J.M.G.), Oregon Health and Science University, Portland, Ore; Cardiovascular Division (C.P.H.), Beth Israel Deaconess Medical Center, Boston, Mass; and Cardiovascular Division (J.C.F.), University Hospital-Case Medical Center, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Glickman","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division (J.M.G., A.S.D., C.P.H., J.N.G., M.M.G., J.C.F.), Brigham and Women\u2019s Hospital, Boston, Mass; Cardiovascular Division (J.M.G.), Oregon Health and Science University, Portland, Ore; Cardiovascular Division (C.P.H.), Beth Israel Deaconess Medical Center, Boston, Mass; and Cardiovascular Division (J.C.F.), University Hospital-Case Medical Center, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Givertz","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division (J.M.G., A.S.D., C.P.H., J.N.G., M.M.G., J.C.F.), Brigham and Women\u2019s Hospital, Boston, Mass; Cardiovascular Division (J.M.G.), Oregon Health and Science University, Portland, Ore; Cardiovascular Division (C.P.H.), Beth Israel Deaconess Medical Center, Boston, Mass; and Cardiovascular Division (J.C.F.), University Hospital-Case Medical Center, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division (J.M.G., A.S.D., C.P.H., J.N.G., M.M.G., J.C.F.), Brigham and Women\u2019s Hospital, Boston, Mass; Cardiovascular Division (J.M.G.), Oregon Health and Science University, Portland, Ore; Cardiovascular Division (C.P.H.), Beth Israel Deaconess Medical Center, Boston, Mass; and Cardiovascular Division (J.C.F.), University Hospital-Case Medical Center, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01324740"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370070041006"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.107177"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00056-9"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(97)00931-4"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(99)00226-X"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2003.06.021"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.11.004"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00296-4"},{"key":"e_1_3_2_10_2","first-page":"268","volume":"17","year":"1998","unstructured":"Kirsh M, Baufreton C, Naftel DC, Benvenuti C, Loisance DY. Prestransplantation risk factors for heat after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant. 1998; 17: 268\u2013277.","journal-title":"J Heart Lung Transplant"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(98)70171-0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.118274"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(03)00478-8"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2004.09.012"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.05.015"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90084-O"},{"key":"e_1_3_2_17_2","first-page":"159","volume":"104","year":"1981","unstructured":"Arcidi JM Jr, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathology study of 1000 subjects at autopsy. Am J Pathol. 1981; 104: 159\u2013166.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_18_2","first-page":"63","volume":"106","year":"1982","unstructured":"Wanless IR, Bernier V, Seger M. Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study. Am J Pathol. 1982; 106: 63\u201370.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(83)80293-7"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(86)80043-5"},{"key":"e_1_3_2_21_2","first-page":"1232","volume":"21","year":"1995","unstructured":"Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology. 1995; 21: 1232\u20131237.","journal-title":"Hepatology"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4065\/79.4.492"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50062"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01339.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2002.1526"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00142-8"},{"key":"e_1_3_2_27_2","first-page":"67","volume":"22","year":"1999","unstructured":"Parera A, Banares R, Alvarez R, Casariego J, Carneros JA, Saicedo M, Palomo J, Cos E. The usefulness of transjugular hepatic biopsy in the evaluation of liver disease in candidates for heart transplantation. Gastroenterol Hepatol. 1999; 22: 67\u201371.","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02886-2"}],"container-title":["Circulation: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCHEARTFAILURE.109.872556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T21:35:44Z","timestamp":1715549744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCHEARTFAILURE.109.872556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1161\/CIRCHEARTFAILURE.109.872556"],"URL":"https:\/\/doi.org\/10.1161\/circheartfailure.109.872556","relation":{},"ISSN":["1941-3289","1941-3297"],"issn-type":[{"value":"1941-3289","type":"print"},{"value":"1941-3297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"2009-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}